Sitemap
- Home
- Solutions
- Bioavailability Enhancement
- Low Dosage APIs
- Fast Track Into Man
- Improving API stability
- Polymorphism solutions
- Targeted and controlled release
- DuoCap - capsule-in-capsule technology
- ENCODE - Colonic Delivery
- Abusolve - abuse detterent formulations
- Targeted delivery of biomolecules
- Probiotic product development
- Services
- About Encap
- Resource Library
- Contact
- News & Events
- All News
- Encap's £3 million high potency manufacturing expansion is officially opened
- Robbie Stewart joins as Sales Director
- Encap Drug Delivery Strengthens Capability in High-Potency and Cytotoxic Encapsulation
- Dr. Stephen Brown joins as R&D Director
- Encap Drug Delivery Announces Plans for Expansion
- 2008 Innovation Award Winners
- Increased US focus for Encap
- ABUSOLVE Used for Abuse Resistant Opioid
- Encap Drug Delivery celebrates 20 year anniversary
- MHRA audit success
- Encap and Probac AB announce exclusive collaboration agreement
- Encap Newsletter is Launched
- Encap Drug Delivery announces colonic drug delivery licensing deal
- Encap announces working partnership with Alfa Chemicals
- Encap hosts Oral Drug Delivery seminar in Edinburgh
- Jane Fraser joins as R&D Director
- Encap Drug Delivery receives patent approval for DuoCap capsule system
- All Events
- CPhI (ICSE) 2009
- CPhI (ICSE) 2008
- AAPS Workshop, Baltimore, USA
- The Center for Professional Advancement Granulation, Tabletting and Capsule Technology Course
- Bench2Boardroom 2008
- AAPS 2009
- AAPS 2008
- CPhI 2010
- AAPS 2010
- CPhI Japan 2010
- Encap Liquid Fill Workshop
- The 37th Annual Meeting and Exposition of The Controlled Release Society
- The Science of Medicines - UK PharmSci 2010
- All News
- Mailing List
- Careers at Encap
- Privacy Policy
- Accessibility
Copyright © Encap 2010
Web design: Net Resources